comparemela.com

MaxCyte, Inc. (NASDAQ:MXCT – Get Rating) CEO Douglas Doerfler sold 7,470 shares of the company’s stock in a transaction that occurred on Tuesday, April 4th. The shares were sold at an average price of $5.03, for a total value of $37,574.10. Following the completion of the transaction, the chief executive officer now directly owns 333,197 […]

Related Keywords

Douglas Doerfler ,Nasdaq ,Morgan Stanley ,Stonepine Capital Management ,Securities Exchange Commission ,Millennium Management ,Maxcyte Inc ,Get Rating ,Exchange Commission ,Financial Advisors ,Capital Management ,Maxcyte Daily ,Maxcyte ,Nasdaq Mxct ,Mxct ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.